SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
SCHEDULE 13G
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 and 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )
Educational Medical, Inc.
_________________________________________________________________
(Name of Issuer)
Common Stock
_________________________________________________________________
(Title of Class of Securities)
0002814901
_________________________________________________________________
(CUSIP Number)
________________________
Page 1 of 5 Pages
<PAGE>
CUSIP No. 0002814901 Page 2 of 5 Pages
_________________________________________________________________
1) Name of Reporting Person Lawrence, Tyrrell,
S.S. or I.R.S. Identification Ortale & Smith
No. of Above Person
_________________________________________________________________
2) Check the Appropriate Box (a) [ ]
if a Member of a Group (b) [ ]
_________________________________________________________________
3) SEC Use Only
_________________________________________________________________
4) Citizenship or Place New York
of Organization
_________________________________________________________________
Number of 5) Sole Voting 995,307 shares of
Shares Beneficially Power Common Stock
Owned by Each
Reporting Person
With: ________________________________________
6) Shared Voting
Power -0-
_______________________________________
7) Sole Disposi- 995,307 shares of
tive Power Common Stock
________________________________________
8) Shared Dis-
positive Power -0-
________________________________________
9) Aggregate Amount Beneficially 995,307 shares of
Owned by Each Reporting person Common Stock
_________________________________________________________________
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
_________________________________________________________________
11) Percent of Class
Represented by 14.9%
Amount in Row (9)
_________________________________________________________________
12) Type of Reporting
Person PN
<PAGE>
CUSIP No. 0002814901 Page 3 of 5 Pages
Item 1(a) - Name of Issuer: Educational Medical, Inc.
Item 1(b) - Address of Issuer's Principal Executive Offices:
1327 North Meadow Parkway
Roswell, GA 30076
Item 2(a) - Name of Person Filing:
This Statement is being filed by Lawrence,
Tyrrell, Ortale & Smith ("LTOS"). LTOS is a New
York limited partnership. Its sole general
partner is Lawrence Venture Partners, a New York
general partnership.
Item 2(b) - Address of Principal Business Office or, if none,
Residence:
515 Madison Avenue, 29th Floor
New York, New York 10022
Item 2(c) - Place of Organization:
New York
Item 2(d) - Title of Class of Securities:
Common Stock
Item 2(e) - CUSIP Number: 0002814901
Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or
13d-2(b):
Not applicable
Item 4 - Ownership.
(a) Amount Beneficially Owned:
995,307 shares of Common Stock
<PAGE>
CUSIP No. 0002814901 Page 4 of 5 Pages
(b) Percent of Class:
14.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the
vote: 995,307
(ii) shared power to vote or to direct
the vote: -0-
(iii) sole power to dispose or to direct
the disposition of: 995,307
(iv) shared power to dispose or to
direct the disposition of: -0-
Item 5 - Ownership of Five Percent or Less of a Class:
Not applicable
Item 6 - Ownership of More than Five Percent on Behalf of
Another Person:
Not applicable
Item 7 - Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on By the Parent Company:
Not applicable
Item 8 - Identification and Classification of Members of
the Group:
Not applicable
Item 9 - Notice of Dissolution of Group:
Not applicable
Item 10 - Certification:
Not applicable
<PAGE>
CUSIP No. 0002814901 Page 5 of 5 Pages
Signature:
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
LAWRENCE, TYRRELL, ORTALE & SMITH
By: Lawrence Venture Partners,
General Partner
By /s/ Richard W. Smith
_____________________________
General Partner
Date: January 14, 1997
